Cargando…

Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients

Background. Helicobacter pylori chronically colonizes gastric/duodenal mucosa and induces gastroduodenal disease and vigorous humoral and cellular immune responses. Methods. In order to clarify the immunological changes induced by this infection, we determined the percentage and, as indicated, ratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Satoh, Yuka, Ogawara, Hatsue, Kawamura, Osamu, Kusano, Motoyasu, Murakami, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320021/
https://www.ncbi.nlm.nih.gov/pubmed/22536220
http://dx.doi.org/10.1155/2012/819842
_version_ 1782228775368392704
author Satoh, Yuka
Ogawara, Hatsue
Kawamura, Osamu
Kusano, Motoyasu
Murakami, Hirokazu
author_facet Satoh, Yuka
Ogawara, Hatsue
Kawamura, Osamu
Kusano, Motoyasu
Murakami, Hirokazu
author_sort Satoh, Yuka
collection PubMed
description Background. Helicobacter pylori chronically colonizes gastric/duodenal mucosa and induces gastroduodenal disease and vigorous humoral and cellular immune responses. Methods. In order to clarify the immunological changes induced by this infection, we determined the percentage and, as indicated, ratios of the following cells in peripheral blood of 45 H. pylori-infected patients and 21 control subjects: CD4(+) T cell, CD8(+) T cells, T helper 1 cells (Th1), T helper 2 cells (Th2), CD4(+)CD25(+) T cells, Foxp3(+) regulatory T cells (Tregs), CD4/CD8 ratio, and Th1/Th2 ratio. Results. The percentage of CD8(+) T cells was significantly lower in H. pylori-infected patients (mean ± SD; 18.0 ± 7.1%) compared to control subjects (mean ± SD; 23.2 ± 7.8%) (P < 0.05). The CD4/CD8 ratio was significantly higher in H. pylori-infected patients (mean ± SD; 3.1 ± 2.4) compared to control subjects (mean ± SD; 2.1 ± 1.0) (P < 0.05). The Th1/Th2 ratio was significantly lower in H. pylori-infected patients (mean ± SD; 10.0 ± 8.5) compared to control subjects (mean ± SD; 14.5 ± 9.0) (P < 0.05). The percentage of CD4(+)CD25(+) T cells in H. pylori-infected patients (mean ± SD; 13.2 ± 6.2%) was significantly higher than that in control subjects (mean ± SD; 9.8 ± 3.4%) (P < 0.05). However, there was no significant difference in Tregs. Conclusion. Tregs did not decrease, but the activation of humoral immunity and Th2 polarization were observed in the peripheral blood of H. pylori-infected patients. In some cases, these changes may induce systemic autoimmune diseases.
format Online
Article
Text
id pubmed-3320021
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33200212012-04-25 Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients Satoh, Yuka Ogawara, Hatsue Kawamura, Osamu Kusano, Motoyasu Murakami, Hirokazu Gastroenterol Res Pract Research Article Background. Helicobacter pylori chronically colonizes gastric/duodenal mucosa and induces gastroduodenal disease and vigorous humoral and cellular immune responses. Methods. In order to clarify the immunological changes induced by this infection, we determined the percentage and, as indicated, ratios of the following cells in peripheral blood of 45 H. pylori-infected patients and 21 control subjects: CD4(+) T cell, CD8(+) T cells, T helper 1 cells (Th1), T helper 2 cells (Th2), CD4(+)CD25(+) T cells, Foxp3(+) regulatory T cells (Tregs), CD4/CD8 ratio, and Th1/Th2 ratio. Results. The percentage of CD8(+) T cells was significantly lower in H. pylori-infected patients (mean ± SD; 18.0 ± 7.1%) compared to control subjects (mean ± SD; 23.2 ± 7.8%) (P < 0.05). The CD4/CD8 ratio was significantly higher in H. pylori-infected patients (mean ± SD; 3.1 ± 2.4) compared to control subjects (mean ± SD; 2.1 ± 1.0) (P < 0.05). The Th1/Th2 ratio was significantly lower in H. pylori-infected patients (mean ± SD; 10.0 ± 8.5) compared to control subjects (mean ± SD; 14.5 ± 9.0) (P < 0.05). The percentage of CD4(+)CD25(+) T cells in H. pylori-infected patients (mean ± SD; 13.2 ± 6.2%) was significantly higher than that in control subjects (mean ± SD; 9.8 ± 3.4%) (P < 0.05). However, there was no significant difference in Tregs. Conclusion. Tregs did not decrease, but the activation of humoral immunity and Th2 polarization were observed in the peripheral blood of H. pylori-infected patients. In some cases, these changes may induce systemic autoimmune diseases. Hindawi Publishing Corporation 2012 2012-03-28 /pmc/articles/PMC3320021/ /pubmed/22536220 http://dx.doi.org/10.1155/2012/819842 Text en Copyright © 2012 Yuka Satoh et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Satoh, Yuka
Ogawara, Hatsue
Kawamura, Osamu
Kusano, Motoyasu
Murakami, Hirokazu
Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients
title Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients
title_full Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients
title_fullStr Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients
title_full_unstemmed Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients
title_short Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients
title_sort clinical significance of peripheral blood t lymphocyte subsets in helicobacter pylori-infected patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320021/
https://www.ncbi.nlm.nih.gov/pubmed/22536220
http://dx.doi.org/10.1155/2012/819842
work_keys_str_mv AT satohyuka clinicalsignificanceofperipheralbloodtlymphocytesubsetsinhelicobacterpyloriinfectedpatients
AT ogawarahatsue clinicalsignificanceofperipheralbloodtlymphocytesubsetsinhelicobacterpyloriinfectedpatients
AT kawamuraosamu clinicalsignificanceofperipheralbloodtlymphocytesubsetsinhelicobacterpyloriinfectedpatients
AT kusanomotoyasu clinicalsignificanceofperipheralbloodtlymphocytesubsetsinhelicobacterpyloriinfectedpatients
AT murakamihirokazu clinicalsignificanceofperipheralbloodtlymphocytesubsetsinhelicobacterpyloriinfectedpatients